Nevro Wins FDA Approval to Launch Spinal Stimulation Trial

Menlo Park, Calif.-based Nevro Corp. touted FDA approval to launch a pivotal clinical trial of its high-frequency spinal cord stimulation system in treatment of chronic pain.  
Mass Device